Target intelligence / Profile preview

ribosomal protein L21 pseudogene 11 (RPL21P11)

Target: RPL21P11
Molecular classification: Other (Pseudogene; does not belong to functional protein families such as receptor, enzyme, transporter, etc.)

Overview

RPL21P11 is a processed pseudogene of ribosomal protein L21, meaning it is a DNA sequence similar to the true RPL21 gene but does not encode a functional protein[4][6]. Pseudogenes such as RPL21P11 typically arise from duplication or retrotransposition events and do not participate in ribosome structure or function. While RPL21 is part of the large 60S ribosomal subunit, RPL21P11 is one of the many non-functional copies dispersed throughout the genome. There is no evidence that RPL21P11 has biological activity, disease association, or value as a therapeutic target[4][6].

Other names: RPL21_50_1399RPL21P11

Mechanism of action

None (Not druggable)

Biological functions

Other (No known biological function; non-coding)

Disease associations

Other (No known disease association; the functional analog RPL21, not RPL21P11, may be mutated in hypotrichosis simplex of the scalp)

Safety considerations

None (No therapeutic or safety relevance)

Interacting drugs

None (No drugs interact with a pseudogene)

Biomarkers

None (Not used for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on ribosomal protein L21 pseudogene 11 (RPL21P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L21 pseudogene 11 (RPL21P11).

Explore the full profile